Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells
Overview
Authors
Affiliations
Natural regulatory T (Treg) cells interfere with multiple functions, which are crucial for the development of strong anti-tumour responses. In a model of 4T1 mammary carcinoma, depletion of CD25+Tregs results in tumour regression in Balb/c mice, but the mechanisms underlying this process are not fully understood. Here, we show that partial Treg depletion leads to the generation of a particular effector CD8 T cell subset expressing CD11c and low level of PD-1 in tumour draining lymph nodes. These cells have the capacity to migrate into the tumour, to kill DCs, and to locally regulate the anti-tumour response. These events are concordant with a substantial increase in CD11b+ resident dendritic cells (DCs) subsets in draining lymph nodes followed by CD8+ DCs. These results indicate that Treg depletion leads to tumour regression by unmasking an increase of DC subsets as a part of a program that optimizes the microenvironment by orchestrating the activation, amplification, and migration of high numbers of fully differentiated CD8+CD11c+PD1lo effector T cells to the tumour sites. They also indicate that a critical pattern of DC subsets correlates with the evolution of the anti-tumour response and provide a template for Treg depletion and DC-based therapy.
Baleviciute A, Radzeviciute E, Zelvys A, Malysko-Ptasinske V, Novickij J, Zinkeviciene A Cancers (Basel). 2022; 14(24).
PMID: 36551739 PMC: 9776811. DOI: 10.3390/cancers14246254.
Nebot-Bral L, Hollebecque A, Yurchenko A, de Forceville L, Danjou M, Jouniaux J J Immunother Cancer. 2022; 10(7).
PMID: 35896284 PMC: 9335020. DOI: 10.1136/jitc-2022-005059.
The Multifaceted Role of Regulatory T Cells in Breast Cancer.
Kos K, de Visser K Annu Rev Cancer Biol. 2021; 5:291-310.
PMID: 34632244 PMC: 7611782. DOI: 10.1146/annurev-cancerbio-042920-104912.
Prediagnostic breast milk DNA methylation alterations in women who develop breast cancer.
Salas L, Lundgren S, Browne E, Punska E, Anderton D, Karagas M Hum Mol Genet. 2020; 29(4):662-673.
PMID: 31943067 PMC: 7068171. DOI: 10.1093/hmg/ddz301.
Chen H, Luan X, Paholak H, Burnett J, Stevers N, Sansanaphongpricha K Nanomedicine (Lond). 2019; 15(1):77-92.
PMID: 31868112 PMC: 7132783. DOI: 10.2217/nnm-2019-0190.